Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Approved

Current status date:

2021-04-30

Product name:

INPROSUB

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02515504

Product Monograph/Veterinary Labelling:

Date: 2021-06-21 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

IBSA INSTITUT BIOCHIMIQUE SA
Via Del Piano P.O. Box 266
Pambio-Noranco
Ticino
Switzerland  6915

Class: 

Human

Dosage form(s):

Solution

Route(s) of administration:

Subcutaneous

Number of active ingredient(s):

1

Schedule(s):

Prescription  

American Hospital Formulary Service (AHFS): See footnote 3

68:32.00   PROGESTINS

Anatomical Therapeutic Chemical (ATC): See footnote 4

G03DA04  PROGESTERONE

Active ingredient group (AIG) number:See footnote 5

0106327010

List of active ingredient(s)
Active ingredient(s) Strength
PROGESTERONE 25 MG / 1.112 ML

Application information

Related information

Contact us

Version 3.9.1
Date modified: